drugset / Trial / NCT01086475

D-Cycloserine and Social Skills Training in Autism Spectrum Disorders

NCT01086475

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of D-cycloserine for improving social impairment in child with pervasive developmental disorders (PDD).

Timeline

Start
2010-03
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule 50 mg

Indications